The talk about the potential of legalization has usually been characterised by two positions: Some Medical professionals and overall health industry experts warn towards trivializing cannabis. Neurologist Euphrosyne Gouzoulis-Mayfrank, incoming president in the German Society for Psychiatry, Psychotherapy and Psychosomatics (DGPPN), has claimed